HYBRID EVENT: You can participate in person at Tokyo, Japan from your home or work.
Cervical cancer screening is a crucial preventive healthcare measure for women. This screening aims to detect abnormalities in the cervix early on, allowing for timely intervention and reducing the risk of cervical cancer development. The primary method of cervical cancer screening is the Pap test (Pap smear). During this procedure, a healthcare provider collects cells from the cervix, which are then examined for any abnormalities or precancerous changes. Pap tests have been instrumental in significantly decreasing the incidence and mortality rates associated with cervical cancer. In addition to the Pap test, human papillomavirus (HPV) testing is often performed in conjunction. Identifying the presence of high-risk HPV strains helps in identifying individuals at an increased risk of developing cervical cancer. Screening guidelines may vary based on age, risk factors, and individual medical history. It is essential for women to discuss their specific situation with their healthcare provider to determine the most appropriate screening schedule. Regular cervical cancer screening is crucial for maintaining women's reproductive health and preventing the progression of potential abnormalities into cervical cancer. Early detection through screening empowers individuals to take proactive steps towards managing their health and reduces the overall burden of cervical cancer on public health systems.
